India’s Covid death toll on Thursday recorded a massive jump after the Bihar revised Covid deaths by 72% to more than 9,000. Because of Bihar’s update, India reported 6,148 new deaths on Thursday, the highest single-day spike.
Bihar’s massive revision in its Covid deaths figure has become controversial and raising more questions. And the opposition in Bihar has been accusing the state government of fudging figures to hide its failure to handle the Covid second wave.
Amid the allegations that the Bihar government was hiding the deaths numbers, the Patna High Court had asked for an audit of casualties during Covid second wave in April-May.
After revising the Covid-19 death toll by nearly 4,000, the Bihar government had said most died in the Covid second wave. Till June 7, the Covid death toll in Bihar was 5,424 which was increased to 9,429 after it was increased by 3,951 fatalities on Wednesday.
The revised fatalities also include people who died due to Covid complications after recovering from the disease and also those who died on the way to the hospital.
On Wednesday, the Nitish Kumar government had reported 9,429 Covid death across the state compared to the figure of 5,500 earlier.
As per the Bihar’s new figure, the most number of Covid deaths reported from the state’s capital Patna -2,303. While the data from three government-run cremation centres in Patna confirms 3,243 Covid cremations.
Chief Minister Nitish Kumar’s native district Nalanda has recorded 222 deaths.
India recorded 92,596 new Covid cases on Thursday while the new fatalities reached at 6,148 after Bihar revised its toll figures on Wednesday.
The top five states which recorded the maximum number of cases are Tamil Nadu with 17,321 cases, followed by Kerala with 16,204 cases, Maharashtra with 10,989 cases, Karnataka with 10,959 cases and Andhra Pradesh with 8,766 cases. As per the updated data, 68.3% of the new cases on Thursday have been contributed from these five states, with Tamil Nadu alone responsible for 18.42% of the new cases.
On the other hand, the Patna’s All India Institute of Medical Sciences will be holding press conference on Thursday with regard to clinical trial on children aged between 2-18 years. Last week, AIIMS Patna had started the pediatric trials for the Covid vaccine manufactured by the Bharat Biotech, Covaxin.
The trial will be conducted on 525 healthy volunteers across different sites across the country. The trial will look into the vaccine’s safety, adverse reactions and their causes.
Read Also: Anique Hashmani: The dependable programmer
On May 11, the Drugs Controller General of India had approved the Covaxin’s clinical trial for children.